AT320138B - Verfahren zur Herstellung neuer antikonzeptioneller Mittel - Google Patents

Verfahren zur Herstellung neuer antikonzeptioneller Mittel

Info

Publication number
AT320138B
AT320138B AT828971A AT828971A AT320138B AT 320138 B AT320138 B AT 320138B AT 828971 A AT828971 A AT 828971A AT 828971 A AT828971 A AT 828971A AT 320138 B AT320138 B AT 320138B
Authority
AT
Austria
Prior art keywords
manufacture
contraceptive agents
new contraceptive
new
agents
Prior art date
Application number
AT828971A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1426670A external-priority patent/CH538283A/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT320138B publication Critical patent/AT320138B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT828971A 1970-09-25 1971-09-24 Verfahren zur Herstellung neuer antikonzeptioneller Mittel AT320138B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1426670A CH538283A (de) 1970-09-25 1970-09-25 Neue antikonzeptionelle Mittel
CH1252471 1971-08-26

Publications (1)

Publication Number Publication Date
AT320138B true AT320138B (de) 1975-01-27

Family

ID=25710428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT828971A AT320138B (de) 1970-09-25 1971-09-24 Verfahren zur Herstellung neuer antikonzeptioneller Mittel

Country Status (10)

Country Link
AT (1) AT320138B (de)
AU (1) AU461935B2 (de)
BE (1) BE773064A (de)
CA (1) CA962595A (de)
DE (1) DE2146239A1 (de)
ES (1) ES395365A1 (de)
FR (1) FR2107969B1 (de)
GB (1) GB1369061A (de)
IL (1) IL37765A (de)
NL (1) NL7113201A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA939565B (en) † 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
AU3380671A (en) 1973-03-29
CA962595A (en) 1975-02-11
AU461935B2 (en) 1975-06-12
GB1369061A (en) 1974-10-02
FR2107969A1 (de) 1972-05-12
NL7113201A (de) 1972-03-28
DE2146239A1 (de) 1972-03-30
BE773064A (fr) 1972-03-24
ES395365A1 (es) 1974-07-16
FR2107969B1 (de) 1975-04-18
IL37765A0 (en) 1972-02-29
IL37765A (en) 1975-03-13

Similar Documents

Publication Publication Date Title
CH531000A (de) Verfahren zur Herstellung neuer Benzocycloheptathiophene
AT311315B (de) Verfahren zur Herstellung neuer Alkoxydinitroaniline
CH541565A (de) Verfahren zur Herstellung neuer substituierter N-Allyl-2-arylamino-imidazoline-(2)
AT309696B (de) Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate
AT326674B (de) Verfahren zur herstellung neuer naphthyridinderivaten
AT318647B (de) Verfahren zur Herstellung neuer Ureidophenoxy-2-hydroxy-3-aminopropane und ihrer Salze
AT300183B (de) Verfahren zur Herstellung antikonzeptioneller Mittel
AT313483B (de) Verfahren zur Herstellung neuer N(6)-Aralkyl-adenosin-Derivate
AT329550B (de) Verfahren zur herstellung neuer benzocycloalkendicarbonsauremonoalkylester
CH530988A (de) Verfahren zur Herstellung neuer Diallylaminoalkanoylamide
AT318920B (de) Verfahren zur Herstellung stabiler Zubereitungen
AT299916B (de) Verfahren zur Herstellung neuer bis-Aminobenzoate
CH516591A (de) Verfahren zur Herstellung neuer Thiazolopyrrolopyrimidine
AT318559B (de) Verfahren zur Herstellung neuer 1-Phenyl-3-hydroxy-3-methyl-triazene
AT306047B (de) Verfahren zur Herstellung neuer 2,9-Dioxatricyclo(4,3,1,0<3,7>decan-4-one
AT320138B (de) Verfahren zur Herstellung neuer antikonzeptioneller Mittel
AT305266B (de) Verfahren zur Herstellung neuer substituierter 2-Benzylphenole
AT301036B (de) Verfahren zur Herstellung neuer Neriifolin-Derivate
ATA451171A (de) Verfahren zur herstellung neuer 4'-alkoxyergotamine
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT319914B (de) Verfahren zur Herstellung neuer Triazapentadiene
AT301772B (de) Verfahren zur Herstellung neuer Dotriacontapeptidamide
AT308114B (de) Verfahren zur Herstellung neuer Piperidinderivate
AT309423B (de) Verfahren zur Herstellung neuer 3-Alkyl-5-aryloxymethyl-isoxazole und ihrer Salze
AT299176B (de) Verfahren zur Herstellung neuer Hexahydrophenanthrenderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee